NDC 0069-1306-01 - RETACRIT
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0069-1306
- Requested NDC
- 0069-1306-01
- Package NDCs from labels
- 0069-1306-01, 0069-1306-10
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc | Hospira, Inc. | Eurofins PROXY Laboratories B.V.
- Effective date
- 2025-06-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| RETACRIT | Pfizer Laboratories Div Pfizer Inc | Hospira, Inc. | Eurofins PROXY Laboratories B.V. | 2025-06-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0069-1306-01 | RETACRIT | 1 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 1 | 19 | |
| 0069-1306-10 | RETACRIT | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 19 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0069-1306-01 | ML - Milliliter | 0069-1306 | a6cf3542-2ad5-4594-998e-2a859d422ad6 | 1 | 2018-06-11 |
| 0069-1306-10 | ML - Milliliter | 0069-1306 | e7909c6b-3133-4c33-b1be-1ae7300d84a4 | 1 | 2018-06-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X M4I0D6VV5M |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.